Background: Melasma is a disorder of acquired facial hyperpigmentation, typically affecting young females. It is known to cause a great psychological impact and a significant negative effect on a patient’s quality of life.
Objectives: To explore the correlation between the quality of life in melasma patients and the severity of melasma.
Methods: This hospital-based, analytical, cross-sectional study was conducted from 2020 October to 2021 December in the Department of Dermatology, Venereology and Leprology of Kathmandu Medical College after institutional ethical clearance, in 101 patients recruited by convenience sampling. The quality of life was calculated using the Nepali version of the Dermatology Life Quality Index (DLQI) questionnaire and severity of melasma was calculated using modified Melasma Area and Severity Index (mMASI). Data analysis was done by SPSS v.24.
Results: The study included 101 patients of melasma with a young female preponderance. Seventy-eight (75.7%) being female and 43 (42.6%) being between the age of 21-30 years. The mean DLQI score was 10.39 ± 3.22; interpreted as having a ‘very large effect on a patient’s life.’ While the mean mMASI score was calculated to be 5.53 ± 2.69; interpreted as a melasma severity score (MSS) of ‘moderate severity.’ A significant positive moderate correlation r = 0.431 (p <0.001) was observed between mMASI and DLQI.
Conclusion: Melasma is a common pigmentary disorder that has a very large effect on the patient’s quality of life and this correlates directly with the severity of melasma.
Guinot C, Cheffai S, Latreille J, Dhaoui MA, Youssef S, Jaber K, et al. Aggravating factors for melasma: A prospective study in 197 Tunisian patients. J Eur Acad Dermatol Venereol. 2010;24(9):1060-9. [Full Text]
Sheth VM, Pandya AG. Melasma: A comprehensive update: part I. J Am Acad Dermatol. 2011;65(4):689- 97. [Full Text]
Kimbrough-Green CK, Griffiths CE, Finkel LJ, Hamilton TA, Bulengo-Ransby SM, Ellis CN, et al. Topical retinoic acid (tretinoin) for melasma in black patients: A vehicle-controlled clinical trial. Arch Dermatol. 1994;130(6):727-33. [Full Text]
Pandya AG, Hynan LS, Bhore R, Riley FC, Guevara IL, Grimes P, et al. Reliability assessment and validation of the melasma area and severity index (masi) and a new modified masi scoring method. J Am Acad Dermatol. 2011;64(1):78-83. [Full Text]
Finlay AY, Khan GK. Dermatology life quality index (dlqi) - A simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210-6. [Full Text]
Rodrigues M, Ayala-Cortés AS, Rodríguez-Arámbula A, Hynan LS, Pandya AG. Interpretability of the modified melasma area and severity index (mmasi). JAMA Dermatol. 2016;152(9):1051-2. [Full Text]
Achar A, Rathi SK. Melasma: A clinicoepidemiological study of 312 cases. Indian J Dermatol. 2011;56(4):380-2. [Full Text]
Krupashankar DSR, Somani VK, Kohli M, Sharad J, Ganjoo A, Kandhari S, et al. A cross-sectional, multicentric clinico-epidemiological study of melasma in india. Dermatol Ther (Heidelb). 2014;4(1):71-81. [Full Text]
Yalamanchili R, Shastry V, Betkerur J. Clinicoepidemiological study and quality of life assessment in melasma. Indian J Dermatol.2015;60(5):519. [Full Text]
Pudasaini P, Neupane S. An observational study to evaluate quality of life in patients with melasma in a tertiary level hospital of pokhara. Nepal Journal of Dermatology, Venereology and Leprology. 2021;19(1):37-41. [Full Text]
Harumi O, Goh CL. The effect of melasma on the quality of life in a sample of women living in Singapore. J Clin Aesthet Dermatol. 2016;9(1):21-4. [Full Text]
Amatya B, Jha AK, Shrestha S. Frequency of different types of facial melanoses referring to the department of dermatology and venereology, nepal medical college and teaching hospital in 2019, and assessment of their effect on the healthrelated quality of life. BMC Dermatol. 2020;20(1):4. [Full Text]
Suthanther CB, Bubna AK, Sankarasubramanian A, Veeraraghavan M, Rangarajan S, Muralidhar K. A clinical study of melasma and assessment of dermatology life quality index at a tertiary healthcare centre in south india. Pigment International. 2016;3(2):77-82. [Full Text]
Ali R, Aman S, Nadeem M, Kazmi AH. Quality of life in patients of melasma. J Pak Assoc Derma. 2013 Jun;23(2):143-8. [Full Text]
Ikino JK, Nunes DH, da Silva VPM, Frode TS, Sens MM. Melasma and assessment of the quality of life in brazilian women. An Bras Dermatol. 2015;90(2):196- 200. [Full Text]
Uyanikoglu H, Aksoy M. Quality of life in patients with melasma in turkish women. Dermatol Reports. 2017 Oct 11;9(2):7340. [Full Text]
Morgaonkar M, Gupta S, Vijay A, Jain SK, Sharma M, Agarwal S. Melasma: Its impact on quality of life. Pigment Int.2017;4:39-44. [Full Text]